Author
Listed:
- Joel M. J. Tan
(Hospital for Sick Children
University of Toronto)
- Monica E. Garner
(Hospital for Sick Children
University of Toronto)
- James M. Regeimbal
(Blavatnik Institute, Harvard Medical School)
- Catherine J. Greene
(University of Calgary)
- Jorge D. Rojas Márquez
(Hospital for Sick Children)
- Dustin A. Ammendolia
(Hospital for Sick Children
University of Toronto)
- Adam R. R. McCluggage
(Hospital for Sick Children)
- Taoyingnan Li
(Hospital for Sick Children
University of Toronto)
- Katherine J. Wu
(Blavatnik Institute, Harvard Medical School)
- Marija Cemma
(Hospital for Sick Children
University of Toronto)
- Philip P. Ostrowski
(Hospital for Sick Children
University of Toronto)
- Brian Raught
(University Health Network
University of Toronto)
- Michael S. Diamond
(Washington University School of Medicine)
- Sergio Grinstein
(Hospital for Sick Children
University of Toronto
University of Toronto)
- Robin M. Yates
(University of Calgary)
- Darren E. Higgins
(Blavatnik Institute, Harvard Medical School)
- John H. Brumell
(Hospital for Sick Children
University of Toronto
University of Toronto
Hospital for Sick Children)
Abstract
The type I interferon (IFN) signaling pathway has important functions in resistance to viral infection, with the downstream induction of interferon stimulated genes (ISG) protecting the host from virus entry, replication and spread. Listeria monocytogenes (Lm), a facultative intracellular foodborne pathogen, can exploit the type I IFN response as part of their pathogenic strategy, but the molecular mechanisms involved remain unclear. Here we show that type I IFN suppresses the antibacterial activity of phagocytes to promote systemic Lm infection. Mechanistically, type I IFN suppresses phagosome maturation and proteolysis of Lm virulence factors ActA and LLO, thereby promoting phagosome escape and cell-to-cell spread; the antiviral protein, IFN-induced transmembrane protein 3 (IFITM3), is required for this type I IFN-mediated alteration. Ifitm3−/− mice are resistant to systemic infection by Lm, displaying decreased bacterial spread in tissues, and increased immune cell recruitment and pro-inflammatory cytokine signaling. Together, our findings show how an antiviral mechanism in phagocytes can be exploited by bacterial pathogens, and implicate IFITM3 as a potential antimicrobial therapeutic target.
Suggested Citation
Joel M. J. Tan & Monica E. Garner & James M. Regeimbal & Catherine J. Greene & Jorge D. Rojas Márquez & Dustin A. Ammendolia & Adam R. R. McCluggage & Taoyingnan Li & Katherine J. Wu & Marija Cemma & , 2021.
"Listeria exploits IFITM3 to suppress antibacterial activity in phagocytes,"
Nature Communications, Nature, vol. 12(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24982-0
DOI: 10.1038/s41467-021-24982-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24982-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.